| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |